Mater Clinical Trials
Mater conducts clinical trials in a range of therapeutic areas including Cancer, Neurology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers’ and Babies Health. Clinical trials are an essential component of healthcare. They provide the evidence to evaluate the safety and efficacy of new treatments and diagnostics, and provide alternative treatment options for patients with unmet needs.
Mater currently has over 200 active clinical trials. These trials include commercial pharmaceutical and medical device studies, as well as collaborative group studies and investigator-initiated studies, led by Mater’s researchers and collaborators at The University of Queensland and other leading Australian and international medical research institutions.
Without volunteers, clinical trials are not possible. If you are interested in being involved – you may be a patient with a new diagnosis, a patient with a long term diagnosis or a healthy volunteer – view available trials below or contact the Mater Clinical Trials team.
Clinical Trials are divided into the following categories:
Evaluating eptinezumab with a brief educational intervention for prevention of migraine in patients with migraine and medication overuse headache
Improve outcomes for women and small babies by improving blood flow to the baby in labour, to alleviate fetal distress.
Are you healthy and undergoing routine colonoscopy and are interested in participating in research that may help increase the effectivness of treatment in patients with inflammatory bowel disease?
Trial Status:
Active, not recruiting
|
An Investigation of the effects of Photobiomodulation (PBM) therapy on Pain and functional Mobility in people with knee osteoarthritis not awaiting knee replacement surgery (a pilot study with wait-list control)
A clinical trial to assess the safety of an experimental device implanted under the scalp for continuous recording of brain electrical activity associated the epileptic seizures
The purpose of this study is to investigate if a new treatment for breast cancer, known as gedatolisib, is safe and effective when combined with other drugs in the treatment of breast cancer that is advanced or that has spread to other parts of your body.
A clinical trial of Ozanimod for treatment for Crohn’s Disease
Trial Status:
Active, not recruiting
|
A potential new treatment for advanced ovarian, peritoneal or fallopian tube cancer.